Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 3, 2012, Pages 566-578

  Ogunwobi, Olorunseun O ^a,b   Wang, Ton ^a   Zhang, Lucy ^a   Liu, Chen ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Chemoprevention; Cyclooxygenase 2; Epithelial mesenchymal transition; Growth factors; Hepatocellular carcinoma

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; COLLAGEN TYPE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; PROSTAGLANDIN E2; PROTEIN KINASE B; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

EID: 84863116289     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06980.x     Document Type: Article

References (26)

1. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127: 679-95.
2. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009; 9: 265-73.
3. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009; 119: 1420-8.
4. Behrens J, Mareel MM, Vanroy FM, Birchmeier W. Dissecting tumor-cell invasion-epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 1989; 108: 2435-47.
5. Thompson EW, Torri J, Sabol M etal. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin. Exp. Metastasis 1994; 12: 181-94.
6. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. Transforming growth factor-beta 1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 2007; 282: 22089-101.
7. Guan F, Handa K, Hakomori SI. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc. Natl Acad. Sci. U.S.A. 2009; 106: 7461-6.
8. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132: 3151-61.
9. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol. Res. Pract. 1998; 194: 701-4.
10. Shariff MIF, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev. Gastroenterol. Hepatol. 2009; 3: 353-67.
11. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract. Res. Clin. Gastroenterol. 2005; 19: 3-23.
12. Zhu HZ, Dong HJ, Eksioglu E etal. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 2007; 133: 1649-59.
13. Shiota G, Okubo M, Noumi T etal. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 407-12.
14. Koga H, Sakisaka S, Ohishi M etal. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 1999; 29: 688-96.
15. Bae SH, Jung FS, Park YM etal. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin. Cancer Res. 2001; 7: 1410-18.
16. Sheng SJ, Qiao M, Pardee AB. Metastasis and AKT activation. J. Cell. Physiol. 2009; 218: 451-4.
17. Ogunwobi OO, Beales ILP. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways. Regul. Pept. 2006; 134: 1-8.
18. Ogunwobi O, Mutungi G, Beales ILP. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 2006; 147: 4505-16.
19. Ogunwobi OO, Liu C. Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin. Exp. Metastasis 2011; 28: 721-31.
20. Kittaka N, Takemasa I, Takeda Y etal. Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. Eur. J. Cancer 2008; 44: 885-97.
21. Ogunwobi OO, Beales ILP. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol. Cell. Endocrinol. 2008; 285: 43-50.
22. Campard D, Lysy PA, Najimi M, Sokal EFM. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008; 134: 833-48.
23. Jenkins DD, Streetz K, Tataria M etal. Donor-derived, liver-specific protein expression after bone marrow transplantation. Transplantation 2004; 78: 530-6.
24. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002; 2: 442-54.
25. Maier HJ, Schmidt-Strassburger U, Huber MA, Wiedemann EM, Beug H, Wirth T. NF-kappa B promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett. 2010; 295: 214-28.
26. Massague J. TGF beta in cancer. Cell 2008; 134: 215-30.